Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare subtype of pyoderma gangrenosum disease characterized by rapidly progressive, single or multiple, painful, aseptic ulcers which present overhanging, violaceous and undermined borders, surrounding induration and erythema, and granulation tissue (occasionally necrotic tissue and/or a purulent exudate) at the base, mainly affecting the legs (but other body surfaces may also be involved), leading to chronic ulcerations and often regressing with cribriform mutilating scars. The disease presents a chronic relapsing course and systemic features (e.g. fever, malaise, arthralgia, myalgia) may be associated.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE3, 1 PHASE2. Research is sponsored by a mix of industry and academic institutions.
9 publications have been identified in PubMed for classic pyoderma gangrenosum. Research spans Case Report / Case Series (78%), Review / Meta-Analysis (11%), and Clinical Trial Publication (11%).
Aly S (2026). [PMID: 41551110](https://pubmed.ncbi.nlm.nih.gov/41551110/). *SAGE Open Med Case Rep*. [Case Report / Case Series]
Tirado-Sánchez A (2025). [PMID: 40543293](https://pubmed.ncbi.nlm.nih.gov/40543293/). *Med Clin (Barc)*. [Clinical Trial Publication]
Dickson D (2025). [PMID: 41487785](https://pubmed.ncbi.nlm.nih.gov/41487785/). *Cureus*. [Case Report / Case Series]
Ben Brahim M (2025). [PMID: 41444690](https://pubmed.ncbi.nlm.nih.gov/41444690/). *J Med Case Rep*. [Case Report / Case Series]
Xin W (2025). [PMID: 40260260](https://pubmed.ncbi.nlm.nih.gov/40260260/). *Front Immunol*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about classic pyoderma gangrenosum
Meena A (2024). [PMID: 39050081](https://pubmed.ncbi.nlm.nih.gov/39050081/). *Indian Dermatol Online J*. [Case Report / Case Series]
Chadli S (2024). [PMID: 38784334](https://pubmed.ncbi.nlm.nih.gov/38784334/). *Cureus*. [Case Report / Case Series]
Kamal K (2024). [PMID: 38110114](https://pubmed.ncbi.nlm.nih.gov/38110114/). *J Invest Dermatol*. [Review / Meta-Analysis]
Manalo-Legas DMLM (2024). [PMID: 39431260](https://pubmed.ncbi.nlm.nih.gov/39431260/). *Acta Med Philipp*. [Case Report / Case Series]